We are optimistic of further growth in
Indonesia, capitalising on the country’s
population growth, increasing affluence
and rising demand for better, affordable
and quality healthcare products.
Both our logistics and distribution arm, PT Millennium Pharmacon International Tbk (MPI) and our manufacturing arm, PT Errita Pharma (Errita) have contributed to the expansion of our operations in Indonesia, which have continued to see positive results.
MPI, which is publicly traded, has grown steadily by double digits since joining the Group in December 2004. MPI is one of the top 10 pharmaceutical logistics and distribution companies in Indonesia, with a central warehouse in Jakarta and 33 branches throughout the country. MPI’s main revenue contributor is the sale of ethical drugs, over-the-counter (OTC) products and disposable medical supplies for 30 principals, including Errita.
Errita is a manufacturer of pharmaceutical and OTC products, renowned for their general pharmaceutical (solid, semi-solid, liquid) and penicillin plants (solid and dry syrup). Joining the Group in 2014, the company employs close to 400 individuals and has registered 126 different products to date. As part of its strategy to increase its overall market share, the company intends to roll out fifteen new products annually.
PT Millennium Pharmacon International Tbk
PT Errita Pharma
Newly Registered Products
STANDARDS & COMPLIANCE